We used rosters of the Crohn's and Colitis Foundation of America to identify potential cases and peer-nominated controls to explore the reported association between oral contraceptives and inflammatory bowel disease. Overall, women who used oral contraceptives were at increased risk of developing Crohn's disease (odds ratio = 1.49, 95% confidence interval (CI) = 0.99-2.26). The findings persisted after adjustment for age at symptom onset, decade of onset, education, marital status, and location of disease. There was an interaction with cigarette smoking; the risk associated with oral contraceptives was elevated in current smokers (odds ratio = 2.64, 95% CI = 1.22-5.75), but not in former smokers or never-smokers. The risk was not elevated for ulcerative colitis (odds ratio = 1.10, 95% CI = 0.65-1.85).
PMID 1637902 1637902 DOI 10.1097/00001648-199207000-00014 10.1097/00001648-199207000-00014
Cite this article
Sandler, R., Wurzelmann, J. I., & Lyles, C. (1992). Oral contraceptive use and the risk of inflammatory bowel disease. *Epidemiology (Cambridge, Mass.)*, *3*(4), 374-378. https://doi.org/10.1097/00001648-199207000-00014
Sandler R, Wurzelmann JI, Lyles C. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology. 1992;3(4):374-378. doi:10.1097/00001648-199207000-00014
Sandler, Robert, et al. "Oral contraceptive use and the risk of inflammatory bowel disease." *Epidemiology (Cambridge, Mass.)*, vol. 3, no. 4, 1992, pp. 374-378.
Cornish JA et al., 2008The American Journal of Gastroenterology
Objectives: Several environmental and genetic factors have been implicated to date in the development of Crohn's disease (CD) and ulcerative colitis (UC). The aim of this study was to provide a quanti...
Contraception/Comparison > Side Effects > Inflammatory Bowel DiseaseResearch Methodology > Study Design > Meta-AnalysisContraception/Comparison > Oral Contraceptives > Autoimmune Risk
Milne RL et al., 2005Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Background: Recent oral contraceptive use has been associated with a small increase in breast cancer risk and a substantial decrease in ovarian cancer risk. The effects on risks for women with germ li...
Contraception/Comparison > Oral Contraceptives > Cancer RiskGeneral OB/GYN > Breast Health > BRCA MutationsResearch Methodology > Epidemiology > Case-Control Studies
Thorogood M et al., 1999British Journal of Obstetrics and Gynaecology
Objective: To examine the risk of multiple sclerosis in users of combined oral contraceptives.
Design: Cohort study conducted between 1968 and 1996 using diagnostic data supplied by general practition...
A multinational hospital-based case-control study of the risk of venous thromboembolic disease associated with combined oral contraceptives (OCs) done in 1989-93 prompted a separate inquiry comparing ...